Medicine and Health

Subterms

    More stories

    • 125 Shares99 Views

      in Elections

      Elizabeth Warren: Don’t Be Fooled. Donald Trump Has a Plan.

      by

      During the presidential debate on Tuesday, Donald Trump was pressed on the details of his plan to repeal Obamacare and replace it with something “better.” The question should’ve been a softball. After all, Mr. Trump has been promising the American people a plan for nine years, so he’s had time to prepare. His answer? After ducking and weaving, he came up with: “I have concepts of a plan.” Uh, that’s not a plan.Plans translate values into action. They test the quality of the ideas and the seriousness of the people advancing them. Plans reveal for whom candidates will fight and how effective they are likely to be. And in a presidential race, if either party’s nominee is asked about his or her plans for something as fundamental as health care, voters should get a straight answer.The problem is not that Mr. Trump can’t think up a way to put his values into action. The problem is that when he and other Republican leaders produce plans with actual details, they horrify the American people.Mr. Trump’s health care values have been on full display for years. In 2017, Republicans controlled Congress, and their first major legislative undertaking was a bill to repeal the Affordable Care Act. Every time they drafted something, independent experts would point out that their plan would toss tens of millions of people off their health insurance, jack up premium costs and slash benefits for those with ongoing health problems.After months of wrangling, Mr. Trump and Republican lawmakers voted a bill through the House to repeal the A.C.A. That night, Mr. Trump hosted a party at the White House to celebrate their big step toward taking away health care from millions of people.A.C.A. repeal then moved to the Senate. Republicans had the majority, so if they all stuck with Mr. Trump, the A.C.A. would die. As senators gathered to vote, nearly all of the Democrats — including Kamala Harris, then a senator from California — remained standing, too anxious even to sit down. We murmured stories about who would be affected by this vote: the uncle who had cancer and would lose coverage, the kid diagnosed with a heart anomaly whose parents wouldn’t be able to find new insurance, the college students who would just go without coverage and hope they didn’t fall on ice or get in a car accident. We felt the weight of people’s lives on the line.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 125 Shares189 Views

      in Elections

      W.H.O. Authorizes Mpox Vaccine, Clearing Way for Use in Africa

      by

      The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.The World Health Organization has given its authorization to a first vaccine to protect against mpox, a decision announced in such haste on Friday that it caught even the head of the company that makes the vaccine by surprise.The vaccine, made by the Danish company Bavarian Nordic, has been approved by the regulatory authorities in Europe as well as the United States and other high-income countries since a global mpox outbreak in 2022. But low- and middle-income countries rely on the W.H.O., through a process called prequalification, to determine which drugs, vaccines and health technologies are safe and efficient uses of limited health funding, and the organization had declined to act until now.The W.H.O. had come under increasing criticism for declaring a global public health emergency for mpox last month without giving a vaccine that prequalification stamp of approval, or a more provisional form of approval called emergency use authorization. Bavarian Nordic first submitted its safety and effectiveness data on the vaccine, called Jynneos, to the W.H.O. in 2023. The W.H.O. had defended its slow pace of review, saying that it needed to subject the vaccine to careful study because it, and two others that have been used to protect against mpox, were originally designed as smallpox immunizations, and because delivering it in low-resource settings such as Central Africa would involve factors different from those relating to its use in high-income countries.But on Friday morning, the W.H.O. suddenly said it was authorizing the shot.“This first prequalification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,” Dr. Tedros Adhanom Ghebreyesus, the W.H.O. director general, said in a statement.Paul Chaplin, Bavarian Nordic’s chief executive, said he was among the many who had been caught off guard.“We’ve got there eventually — I don’t know quite how,” he said. “But it’s good news. It’s going to make the regulatory pathway much easier.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 88 Shares159 Views

      in Elections

      Are Some Ultraprocessed Foods Worse Than Others?

      by

      A new study may offer the biggest clues yet.Name a common condition — heart disease, Type 2 diabetes, cancer, dementia, irritable bowel syndrome — and chances are good that following a diet high in ultraprocessed foods has been linked to it.But the ultraprocessed food category is large and wide-ranging. It makes up an estimated 73 percent of the U.S. food supply, and contains stereotypically “unhealthy” products like sodas, candies and hot dogs as well as seemingly “healthy” ones like whole grain breads, breakfast cereals, flavored yogurts and plant milks.It’s a “hodgepodge of foods,” some of which are likely more harmful than others, said Josiemer Mattei, an associate professor of nutrition at the Harvard T.H. Chan School of Public Health.On Monday, Dr. Mattei and her colleagues published one of the largest and longest studies on ultraprocessed foods and heart health to date. In it, they analyzed the risks of consuming these foods, and teased out the worst offenders.An Overall Risk of Ultraprocessed FoodsThe new study, published in a Lancet journal, included more than 200,000 adults in the United States. They filled out detailed diet questionnaires beginning in the 1980s and early 1990s, and completed them again every two to four years for about 30 years. Most of the participants in the study were white and worked as health professionals. The researchers looked at how the participants’ ultraprocessed food consumption related to their chances of developing cardiovascular disease.After adjusting for risk factors like smoking, family health history, sleep and exercise, the researchers found that those who consumed the most ultraprocessed foods were 11 percent more likely to develop cardiovascular disease and 16 percent more likely to develop coronary heart disease during the study period, compared with those who consumed the least ultraprocessed foods. The highest consumers also had a slightly, but not significantly, elevated risk of stroke.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 75 Shares149 Views

      in Elections

      How Wildfire Smoke Threatens Human Health

      by

      The mucus and hairs in your nose can trap larger particles, and the mucus and cilia in your upper airway can catch some as well, said Luke Montrose, an environmental toxicologist at Colorado State University. But some PM2.5 or smaller particles can bypass these defenses and penetrate the deepest parts of your lungs. Dr. Montrose […] More

    • 88 Shares179 Views

      in Elections

      Can You Uncover the Hidden Book Titles?

      by

      The fever had dissipated but the six patients were having respiratory issues that were resistant to treatment and the next few hours were going to be precarious. Half the group had already crossed the line between serious and critical condition, as two of them were on oxygen and one was on life support.Meanwhile, as investigators examined the body of evidence in the case, their nexus of activity focused on the farm on Lakewood Road, where they would soon find a beautiful poison toadstool that someone had seamlessly blended in with the straw mushrooms for sale.The fever had dissipated but the six patients were having respiratory issues that were resistant to treatment and the next few hours were going to be precarious. Half the group had already crossed the line between serious and critical condition, as two of them were on oxygen and one was on life support.Meanwhile, as investigators examined the body of evidence in the case, their nexus of activity focused on the farm on Lakewood Road, where they would soon find a beautiful poison toadstool that someone had seamlessly blended in with the straw mushrooms for sale.The fever had dissipated but the six patients were having respiratory issues that were resistant to treatment and the next few hours were going to be precarious. Half the group had already crossed the line between serious and critical condition, as two of them were on oxygen and one was on life support.Meanwhile, as investigators examined the body of evidence in the case, their nexus of activity focused on the farm on Lakewood Road, where they would soon find a beautiful poison toadstool that someone had seamlessly blended in with the straw mushrooms for sale. More

    • 163 Shares129 Views

      in Elections

      $1 Billion Bloomberg Gift to Hopkins Makes Tuition Free for Most Medical Students

      by

      The gift, made by Michael R. Bloomberg’s philanthropic organization, will also cover living expenses for some Johns Hopkins University students.A $1 billion gift from Michael Bloomberg to Johns Hopkins University, announced on Monday, will allow most students at the university’s medical school to attend free of cost and will also increase financial aid for other students in the university’s schools of nursing and public health and other graduate programs.Bloomberg Philanthropies, which oversees Mr. Bloomberg’s charitable efforts, said in a statement that the gift would ensure that “the most talented aspiring doctors representing the broadest range of socio-economic backgrounds will have the opportunity to graduate debt-free” from the university.Starting with the fall semester, Johns Hopkins will offer free tuition for medical students from families that earn less than $300,000 annually, Bloomberg Philanthropies said. The university will also pay for living expenses and other fees for students from families earning up to $175,000.Mr. Bloomberg, a former mayor of New York City and a graduate of Johns Hopkins, said in a statement that the high cost of medical school and graduate school “too often bars students from enrolling” at a crucial time when the United States faces a shortage of medical professionals.“By reducing the financial barriers to these essential fields, we can free more students to pursue careers they’re passionate about and enable them to serve more of the families and communities who need them the most,” Mr. Bloomberg said.Other universities have also been able to waive tuition for medical students in recent years. Albert Einstein College of Medicine in the Bronx did so after Ruth Gottesman, a longtime professor there, made a $1 billion donation earlier this year. In 2023, Kenneth G. Langone, a billionaire financier and a founder of Home Depot, and his wife, Elaine Langone, made a $200 million donation to the N.Y.U. Long Island School of Medicine, making tuition free for medical students.This is not the first large contribution to Johns Hopkins from Mr. Bloomberg, who routinely makes donations toward the arts, education, the environment and public health. Bloomberg Philanthropies made a $1.8 billion donation to the university in 2018 as part of an effort to ensure that undergraduate students would be accepted by the university regardless of their family’s income.Ron Daniels, the president of Johns Hopkins University, said in a statement on Monday that “removing financial barriers to individual opportunity fuels excellence, innovation and discoveries that redound to the benefit of society.”The new gift from Mr. Bloomberg will mean that nearly two-thirds of medical students who currently attend Johns Hopkins or who will enter programs at the university soon will be eligible for free tuition or both free tuition and living expenses, according to the university. Those who are eligible will soon receive updated financial aid packages.José Luis Castro, the president and chief executive of Vital Strategies, a nonprofit public health organization, said on social media that the gift to Johns Hopkins was “transformational and inspiring” and that it would “help meet the growing need for doctors and public health professionals.” More

    • 163 Shares199 Views

      in Elections

      Gilead Shot Provides Total Protection From HIV in Trial of Young African Women

      by

      An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.Researchers and activists in the trenches of the long fight against H.I.V. got a rare piece of exciting news this week: Results from a large clinical trial in Africa showed that a twice-yearly injection of a new antiviral drug gave young women total protection from the virus.“I got cold shivers,” said Dr. Linda-Gail Bekker, an investigator in the trial of the drug, lenacapavir, describing the startling sight of a line of zeros in the data column for new infections. “After all our years of sadness, particularly over vaccines, this truly is surreal.”Yvette Raphael, the leader of a group called Advocacy for Prevention of H.I.V. and AIDS in South Africa, said it was “the best news ever.”The randomized controlled trial, called Purpose 1, was conducted in Uganda and South Africa. It tested whether the every-six-months injection of lenacapavir, made by Gilead Sciences, would provide better protection against H.I.V. infection than two other drugs in wide use in high-income countries, both daily pills.The results were so convincing that the trial was halted early at the recommendation of the independent data review committee, which said all participants should be offered the injection because it clearly provided superior protection against the virus.None of the 2,134 women in the arm of the trial who received lenacapavir contracted H.I.V. By comparison, 16 of the 1,068 women (or 1.5 percent) who took Truvada, a daily pill that has been available for more than a decade, and 39 of 2,136 women (1.8 percent) who received a newer daily pill called Descovy were infected.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 100 Shares129 Views

      in Elections

      How Helpful Is Walking for Lower Back Pain?

      by

      A new study adds to a large body of evidence on the effectiveness of movement for treating and preventing pain.Doctors and physical therapists have long incorporated aerobic exercise into treatment programs for lower back pain. Movement can simultaneously ease lower back pain and also strengthen the muscles that support your back. Still, many people with back pain can be hesitant to exercise.A new study, published on Wednesday in The Lancet, offers more evidence on the power of movement. The study found that a regular walking routine can be very effective for preventing the recurrence of back pain. The study focused on adults with a history of low back pain; those who walked regularly went nearly twice as long without their back pain coming back compared to the control group.The new findings are in line with a large body of existing research that has established an association between physical activity and better outcomes for back pain. A 2019 systematic review found that physical activity lowered the prevalence of back pain. And a 2017 study found that yoga worked as well as physical therapy for relieving back pain.The new study builds on this research by following patients outside a tightly controlled clinical setting. Mark Hancock, a professor of physiotherapy at Macquarie University in Australia and a senior author of the study, sought to evaluate the effectiveness of a less expensive intervention that could be easier for many people to access than in-clinic treatment.Dr. Hancock and a team of researchers targeted a relatively sedentary sample group. The researchers collected data on 701 adults who had recently recovered from an episode of low back pain. They were randomly split in two groups: one group received an individualized walking and education program, facilitated by a physiotherapist over six sessions in a six-month period. The other group did not receive any intervention. The researchers followed both groups for the next one to three years.The goal for each person in the walking group was to walk five times per week for at least 30 minutes daily — but the program was highly personalized based on age, body mass index, current activity level, time constraints and personal goals.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More